At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
atherectomydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
3-year Follow-up of Patients Treated With Jetstream Combined With Ranger for Calcified Femoropopliteal Lesions
Association de Provence pour la Promotion de l'Enseignement et la Recherche Cardiologique·observational·Posted Dec 18, 2023·Updated Mar 13, 2026
In Brief
An observational study evaluating atherectomy for Peripheral Artery Disease. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The goal of this non interventional study is to evaluate the long-term clinical effects (3-year follow-up after the procedure) of Jetstream atherectomy combined with a paclitaxel-eluting balloon (Ranger) in all patients who were treated for calcified femoropopliteal lesions (de novo, single or multiple, mono- or bilateral) between December 1, 2016 and December 31, 2020 at the Clinique Rhône-Durance, Avignon, France
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Artery Disease
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
202420252026
Enrollment StartNov 2023
Primary CompletionNov 2023
First PostedDec 2023
Study CompletionJan 2024
TodayJul 2026
First PostedDec 18, 2023
Enrollment StartNov 3, 2023
Primary CompletionNov 3, 2023
Study CompletionJan 29, 2024
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 2.5 years ago
Interventions
atherectomydevice
Jetstream atherectomy in combination with Ranger paclitaxel elution balloon (Drug Coated Balloon (DCB))